BioSpace News Archive

AllStripes, a healthcare technology company dedicated to accelerating treatment research for patients with rare diseases, announced a collaboration with the National Center for Advancing Translational Sciences, an institute of the NIH established to transform the translational process so that new treatments and cures for disease can be delivered to patients faster.

Alydia Health, a commercial-stage medical device company focused on making childbirth safer for all mothers, announced that industry veteran Paul Praino has joined the company as Vice President of Sales.

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating in the upcoming Bank of America Securities 2021 Health Care Conference that is being held virtually from May 10-12, 2021.

Generex receives $2 million payment from Chinese partners to provide research results, data, and necessary documents to support an IND submission to the Chinese National Medical Products Administration (NMPA)

Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the first quarter ended March 31, 2021 on Tuesday, May 4, 2021 after U.S. markets close.

MediXall Group, Inc., an innovative healthcare solutions provider, announced that its subsidiary, Health Karma, is signing up agencies and brokerage firms as part of its new Health Karma Partner Program geared toward building a multi-tiered sales channel to accelerate market adoption.

Existing Clarus investors, led by H. I. G. Capital, will invest an additional $25 million in support of the company Transaction will accelerate commercialization of JATENZO®, the market-leading oral testosterone replacement therapy, and fund expansion of the company’s pipeline of androgen and metabolic therapies for men and women, including orphan indications Clarus Therapeutics shareholders and Blue Water Acquisition Corp. shareholders will hold shares in Clarus Therapeutics

Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) today announces that the Annual Report for 2020 now is available at the company’s website: www.calliditas.com.

Aruvant Sciences (“Aruvant”), a private company focused on developing gene therapies for rare diseases, today announced that data on ARU-1801, a potentially curative gene therapy for sickle cell disease (SCD), will be delivered in an oral presentation at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

PPD, Inc. (Nasdaq: PPD), a leading global contract research organization (CRO), and Science 37, developer of the Decentralized Clinical Trial Operating System™ (DCT OS), today announced an innovative collaboration in which PPD will be fully enabled to design, build, test, implement and execute digital trials using Science 37’s DCT SaaS-based technology platform.